Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Shanghai Stock Exchange  >  Shanghai MicroPort Endovascular MedTech Co., Ltd.    688016   CNE100003MJ5

SHANGHAI MICROPORT ENDOVASCULAR MEDTECH CO., LTD.

(688016)
  Report
End-of-day quote. End-of-day quote Shanghai Stock Exchange - 01/25
337.24 CNY   +3.53%
2020SHANGHAI MICROPORT ENDOVASCULAR MEDTECH CO., LTD. : annual earnings release
SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Summary
  • The company has strong fundamentals. More than 70% of listed companies have a lower mix of growth, profitability, debt and visibility criteria.
Strengths
  • Analysts expect a sharply increasing business volume for the group, with high growth rates in the coming years.
  • Margins returned by the company are among the highest on the stock exchange list. Its core activity clears big profits.
  • Predictions on business development from analysts polled by Standard & Poor's are tight. This results from either a good visibility into core activities or accurate earnings releases.
  • Sales forecast by analysts have been recently revised upwards.
  • Over the last twelve months, the sales forecast has been frequently revised upwards.
  • For the last few months, EPS revisions have remained quite promising. Analysts now anticipate higher profitability levels than before.
  • For the last twelve months, analysts have been gradually revising upwards their EPS forecast for the upcoming fiscal year.
Weaknesses
  • The share is close to its long-term resistance in weekly data. Therefore, the potential should be limited. However, a further bullish movement when crossing this resistance will be a positive signal.
  • Technically, the stock approaches a strong medium-term resistance at CNY 357.
  • With an expected P/E ratio at 113.03 and 81.49 respectively for both the current and next fiscal years, the company operates with high earnings multiples.
  • The company is not the most generous with respect to shareholders' compensation.
Sector Medical Devices & Implants
1st jan.Capitalisation (M$)Investor Rating
SHANGHAI MICROPORT ENDOVASC..34.25%3 746
STRYKER CORPORATION-2.24%90 021
SMITH & NEPHEW PLC6.69%19 251
INSPIRE MEDICAL SYSTEMS, IN..14.27%5 789
VENUS MEDTECH (HANGZHOU) IN..20.24%5 186
GLAUKOS CORPORATION12.90%3 818
AK MEDICAL HOLDINGS LIMITED14.71%2 222
AXONICS MODULATION TECHNOLO..10.88%2 203
CERUS CORPORATION5.20%1 217
JAPAN LIFELINE CO., LTD.-5.78%1 187
ORTHOPEDIATRICS CORP.10.64%892
OSSTEMIMPLANT CO LTD--.--%731
MEDARTIS HOLDING AG-3.98%592
SEASPINE HOLDINGS CORPORATI..-0.17%481
DIO CORP--.--%473
CARMAT1.77%442
More Results
Financials
Sales 2020 446 M 68,9 M 68,9 M
Net income 2020 201 M 31,0 M 31,0 M
Net cash 2020 1 009 M 156 M 156 M
P/E ratio 2020 113x
Yield 2020 0,25%
Capitalization 22 601 M 3 496 M 3 497 M
EV / Sales 2020 48,5x
EV / Sales 2021 33,7x
Nbr of Employees 387
Free-Float 28,8%
Upcoming event on SHANGHAI MICROPORT ENDOVASCULAR MEDTECH CO., LTD.
Notations Surperformance©
  Help  
Fundamental ratings
Overall rating
Trading Rating
Investor Rating
Growth (Revenue)
Valuation -
Finances -
Profitability
Earnings quality -
Business Predictability
P/E ratio
Potential
Yield
Consensus
7 days EPS revision
4 months EPS revision
1 year EPS revision
4 months Revenue revision
1 year Revenue revision
Technical ratings
Short Term Timing
Middle Term Timing
Long Term Timing
RSI
Bollinger Spread
Unusual Volumes